Clinical Report: Short- Versus Long-Duration Antibiotics for Bone Infections

Overview

The supplied article describes a systematic review and meta-analysis designed to compare short- and long-course antibiotic therapy for bacterial bone infections using randomized controlled trials. It plans parallel intention-to-treat and per-protocol analyses and assessment of antibiotic-related adverse events; the provided text does not include the included-trial results or pooled estimates, so comparative efficacy and safety findings cannot be reported.

Background

Osteomyelitis can arise through haematogenous spread or contiguous infection, with the latter associated in the source with trauma, diabetes, and implanted devices. The article reports that recurrence or persistent infection has been described in up to 40% of patients and mortality ranges from 3% to 6%. Treatment generally combines surgical debridement and antibiotics, but the appropriate antibiotic duration remains disputed. Earlier meta-analyses cited by the article were limited by reliance on observational studies and intention-to-treat data.

Data Highlights

The supplied article excerpt provides clinical context and methods but no included-study counts, pooled effect estimates, confidence intervals, or adverse-event results. It reports background estimates of recurrence or persistent infection of up to 40%, mortality of 3–6%, and 2013 survey responses in periprosthetic joint infection management: 41% favored lifelong therapy, 35% several years, and 23% a course lasting months.

Key Findings

• The review question is whether short-course antibiotic therapy differs from long-course therapy for bacterial bone infections.
• Eligibility was restricted to randomized controlled trials comparing short- and long-course treatment and reporting cure or treatment failure and antibiotic-related adverse events.
• Treatment failure was defined as recurrence, persistent infection, or need for an unplanned additional intervention.
• The protocol was prospectively registered in PROSPERO as CRD420261383248, and the review was reported as following PRISMA guidance.
• The search covered PubMed, Embase, the Cochrane Library, and Web of Science from inception through February 2026, with ClinicalTrials.gov also searched for completed unpublished trials.
• The supplied excerpt does not report the number of included trials or the results of the planned intention-to-treat and per-protocol analyses; no conclusion about relative treatment efficacy or safety can therefore be drawn from it.

Clinical Implications

The supplied material does not provide comparative outcome results that would support a general clinical recommendation on antibiotic duration for bone infections. It describes duration as unresolved and notes that treatment practices for periprosthetic joint infection have varied substantially.

Conclusion

This review was designed to address limitations of earlier evidence by restricting inclusion to randomized trials and analyzing both intention-to-treat and per-protocol data. Its findings are not available in the supplied excerpt, so the relative benefits and harms of short- versus long-course therapy remain undetermined here.

Related Resources & Content

1. Article supplied by user, publication details not provided -- Comparing Short- and Long-Duration Antibiotic Therapy for Bone Infections: A Meta-Analysis of Randomized Controlled Trials
2. IDSA, Clinical Practice Guideline, 2015 -- Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults
3. Bernard et al., The Lancet, 2015 -- Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis
4. IWGDF/IDSA, Clinical Practice Guideline, 2023 -- Guidelines on the Diagnosis and Treatment of Diabetes-Related Foot Infections
5. Bernard et al., New England Journal of Medicine, 2021 -- Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection
6. Infection — Comparison of 7-Day versus 14-Day Antimicrobial Therapy in Bacteremia Patients: A Meta-Analysis of Randomized Controlled Trials
7. Open Forum Infectious Diseases — Evaluating the Efficacy of Short-Course Versus Long-Course Antibiotic Treatment for Uncomplicated Infections in Outpatient Solid Tumor Oncology Patients: A Retrospective Cohort Analysis
8. Frontiers in Medicine — Efficacy and safety of short-course antibiotic therapy for community-acquired pneumonia in adults: a meta-analysis
9. MDSpire News — Shorter Antibiotic Courses: Safe for DFO?
10. IDSA 2015 Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults
11. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis
12. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-Related Foot Infections
13. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection
14. IDSA 2015 Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults
15. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial - PubMed
16. IWGDF/IDSA Guidelines on the Diagnosis and Treatment of Diabetes-Related Foot Infections
17. Antibiotic Therapy for 6 or 12 Weeks for Prosthetic Joint Infection | New England Journal of Medicine
18. Periprosthetic Joint Infection: Current Clinical Challenges | Clinical Infectious Diseases | Oxford Academic
19. Short or Long Antibiotic Regimens in Orthopedics | New England Journal of Medicine
20. Short Against Long Antibiotic Therapy for Infected Orthopaedic Sites—2nd Interim Analysis of the SALATIO Trials - PMC
21. Oral versus Intravenous Antibiotics for Bone and Joint Infection | New England Journal of Medicine
22. Oral versus intravenous antibiotics for bone and joint infections: Systematic review and meta-analysis of randomized controlled trials.
23. Antibiotic duration in native and periprosthetic joint infections: a systematic review and meta-analysis of randomized controlled trials - PMC